| ROIVRoivant Sciences Ltd. | 8,285,461 | $229.5M |
| CNTACentessa Pharmaceuticals plc | 5,258,903 | $208.9M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 2,373,795 | $206.4M |
| SYRESpyre Therapeutics, Inc. | 3,783,225 | $190.8M |
| NUVLNuvalent, Inc. | 1,580,505 | $161.9M |
| PTGXProtagonist Therapeutics, Inc | 1,230,879 | $129.7M |
| APGEApogee Therapeutics, Inc. | 1,540,384 | $129.7M |
| TVTXTravere Therapeutics, Inc. | 4,142,551 | $123.1M |
| IMTXImmatics N.V. | 10,383,456 | $102.2M |
| ZYMEZymeworks Inc. | 3,510,078 | $87.9M |
| SLDBSolid Biosciences Inc. | 11,906,646 | $85.7M |
| ORKAOruka Therapeutics, Inc. | 1,395,501 | $68.4M |
| NRIXNurix Therapeutics, Inc. | 3,710,877 | $57.5M |
| CTMXCytomX Therapeutics, Inc. | 10,098,824 | $47.5M |
| IMVTImmunovant, Inc. | 1,597,383 | $39.7M |
| IONSIONIS PHARMACEUTICALS INC | 504,000 | $37.8M |
| DAWNDay One Biopharmaceuticals, Inc. | 1,755,799 | $37.6M |
| ABVXAbivax SA | 328,884 | $36.6M |
| JAZZJazz Pharmaceuticals plc | 170,000 | $32.1M |
| DMRADamora Therapeutics, Inc. | 1,223,000 | $31.7M |
| XFORX4 Pharmaceuticals, Inc | 6,737,648 | $27.8M |
| IVVDInvivyd, Inc. | 20,859,303 | $27.1M |
| SIONSionna Therapeutics, Inc. | 658,439 | $26.4M |
| AXSMAxsome Therapeutics, Inc. | 149,950 | $25.3M |
| RVMDREVOLUTION MEDICINES, INC. | 258,600 | $25.1M |
| SABSSAB BIOTHERAPEUTICS, INC. | 6,431,743 | $24.6M |
| TENXTENAX THERAPEUTICS, INC. | 1,447,782 | $23.2M |
| VRDNViridian Therapeutics, Inc.\DE | 1,170,829 | $22.9M |
| LONALeonaBio, Inc. | 1,859,322 | $19.1M |
| STROSUTRO BIOPHARMA, INC. | 715,307 | $17.8M |
| TNGXTango Therapeutics, Inc. | 808,153 | $16.9M |
| OCSOculis Holding AG | 493,827 | $13.1M |
| IRDOpus Genetics, Inc. | 1,835,842 | $8.4M |
| SRZNSurrozen Inc. | 229,393 | $6.7M |
| AGMBAgomAb Therapeutics NV | 600,000 | $6.3M |
| COGTCogent Biosciences, Inc. | 121,082 | $4.7M |
| ADMAADMA BIOLOGICS, INC. | 467,233 | $4.2M |
| CBIOCRESCENT BIOPHARMA, INC. | 206,942 | $3.8M |
| APLSApellis Pharmaceuticals, Inc. | 80,956 | $3.3M |
| EDSAEdesa Biotech, Inc. | 563,239 | $2.9M |
| ADPTAdaptive Biotechnologies Corp | 152,500 | $2.1M |
| AVTXAvalo Therapeutics, Inc. | 139,667 | $2.1M |
| PTNPALATIN TECHNOLOGIES INC | 61,945 | $1.1M |
| ENSCEnsysce Biosciences Inc. | 86,666 | $47K |